Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Amarin Corporation PLC (AMRN)

« Back to company index

AMRN Chatter Timeline

Stock Ticker for AMRN

Most Active Tweeters for AMRN

UserTweets
@MedResCol 21
@sales_js 21
@TheStockPanther 16
@MarketPimp 13
@1MinuteStock 12

Recent Tweets for AMRN

joaquinkam @joaquinkam
RT @TerraPharma1: $AMRN New US patent application published late last week (on website today) for combo with mipomersen (brand name Kynamro…
October 21st 2019, 8:10pm
monroewarriors5 @monroewarriors5
@haodongvli $AMRN next!
October 21st 2019, 5:10pm
chriskemprealty @chriskemprealty
Good info in here on $AMRN https://t.co/ZsTPyfHZ1C
October 21st 2019, 5:10pm
tabuhasna @tabuhasna
RT @bio_econ: ~ strong recommendation to watch this: https://t.co/XyCXA5Um8q ~ $AMRN $ACST ~ big thanks to @MatthewLepoire and Nathan We…
October 21st 2019, 5:10pm
sansing_david @sansing_david
Great article on $AMRN - A Chat With John Thero, CEO Of Amarin. https://t.co/GtPNBGKHoj
October 21st 2019, 5:10pm
moshakes_911 @moshakes_911
@stockmktgenius @realwillmeade and $AMRN
October 21st 2019, 4:10pm
MedResCol @MedResCol
See, everyone gets a voice: $AMRN https://t.co/pj4B11rRrY
October 21st 2019, 4:10pm
StonesCapital @StonesCapital
$AMRN He seems pretty optimistic about this presentation!! #Vascepa https://t.co/JPTPBYC5KZ
October 21st 2019, 4:10pm
TraderJill77 @TraderJill77
Informal chat with $AMRN CEO https://t.co/cGatrCD5xl
October 21st 2019, 4:10pm
TerraPharma1 @TerraPharma1
$AMRN New US patent application published late last week (on website today) for combo with mipomersen (brand name K… https://t.co/dasIrz0KWH
October 21st 2019, 3:10pm
75234j @75234j
RT @TerraPharma1: A Chat with $AMRN CEO John Thero https://t.co/oIrmekDgJa
October 21st 2019, 2:10pm
tommyrulznyc @tommyrulznyc
@workin4thefam @TerraPharma1 If $amrn is locking up all the “good” fish, what’s in that OTC crap??? ?
October 21st 2019, 2:10pm
PickingMyOwn @PickingMyOwn
RT @MatthewTNatale: $AMRN "A Chat With John Thero, CEO Of Amarin" https://t.co/yBqV2BlaVs $AMRN
October 21st 2019, 2:10pm
TOWiU2 @TOWiU2
@portefeuillefun What is the background of the remarkable difference in top10 positions of the real portfolio vs. vssporte, e.g. $amrn?
October 21st 2019, 1:10pm
ArikCR23 @ArikCR23
$AMRN Anyone who supports AMRN must block Medical Research Collaborative, LLC he just doesn't bring any value in hi… https://t.co/4ItD4qBxYB
October 21st 2019, 1:10pm
MatthewTNatale @MatthewTNatale
$AMRN "A Chat With John Thero, CEO Of Amarin" https://t.co/yBqV2BlaVs $AMRN
October 21st 2019, 1:10pm
TerraPharma1 @TerraPharma1
A Chat with $AMRN CEO John Thero https://t.co/oIrmekDgJa
October 21st 2019, 1:10pm
Arbtrader69 @Arbtrader69
$AMRN - A Chat With John Thero, CEO Of Amarin. https://t.co/E655Uwgj0e
October 21st 2019, 1:10pm
tabuhasna @tabuhasna
A Chat With John Thero, CEO Of Amarin $AMRN https://t.co/mXlz9ELV2E
October 21st 2019, 1:10pm
SeekingAlpha @SeekingAlpha
$AMRN - A Chat With John Thero, CEO Of Amarin. Sign up for updates on Seeking Alpha! https://t.co/UQBbSm0Yjd #stockmarket #finance #stocks
October 21st 2019, 1:10pm
sales_js @sales_js
RT @TraderJill77: The AdComm for $AMRN is Nov 14th for an expanded Vascepa label. It is one of mine, and I've been holding since this summe…
October 21st 2019, 1:10pm
sales_js @sales_js
RT @greenday_bio: $AMRN The call for Vascepa expanded approval from cardiologists / endocrinologists keep pouring in https://t.co/E3I5ZFNB1…
October 21st 2019, 1:10pm
PickingMyOwn @PickingMyOwn
RT @greenday_bio: @TerraPharma1 $AMRN has their own reply to the question https://t.co/G7TIq2yk8P
October 21st 2019, 12:10pm
greenday_bio @greenday_bio
@TerraPharma1 $AMRN People are starting to realize the magnitude of this. Vascepa usage could be so big there might… https://t.co/foV6IkD0Dj
October 21st 2019, 12:10pm
greenday_bio @greenday_bio
@TerraPharma1 $AMRN has their own reply to the question https://t.co/G7TIq2yk8P
October 21st 2019, 12:10pm
TraderJill77 @TraderJill77
The AdComm for $AMRN is Nov 14th for an expanded Vascepa label. It is one of mine, and I've been holding since this… https://t.co/MyWFXnnXwI
October 21st 2019, 11:10am
greenday_bio @greenday_bio
$AMRN The call for Vascepa expanded approval from cardiologists / endocrinologists keep pouring in… https://t.co/gIZZvrypoh
October 21st 2019, 11:10am
bio_econ @bio_econ
~ strong recommendation to watch this: https://t.co/XyCXA5Um8q ~ $AMRN $ACST ~ big thanks to @MatthewLepoire and Nathan Weinstein.
October 21st 2019, 11:10am
TerraPharma1 @TerraPharma1
ESC Debate - it’s the Triglycerides, Pros vs Cons. $AMRN #reduceit #vascepa #omega3 #icosapentethyl https://t.co/xF5FUqVAE1
October 21st 2019, 11:10am
glareone @glareone
$AMRN Monthy target https://t.co/5JyEQtPBgx
October 21st 2019, 9:10am
MatthewTNatale @MatthewTNatale
$AMRN So-so article but it's 100% correct! Future isn't promised but that doesn't mean there isn't a pony in the b… https://t.co/Lpg3fSjByM
October 21st 2019, 9:10am
joaquinkam @joaquinkam
RT @BullLogic: $AMRN $30 coming. Believe it.
October 21st 2019, 8:10am
FaZe_VascepA @FaZe_VascepA
This guy shud quit #10bomb #sbmmTrash $AMRN Vascepa wins #Fortnite #XboxShare https://t.co/1HglgPRuX4
October 21st 2019, 8:10am
JohnCappello @JohnCappello
Pleiotropic health benefits of EPA beyond CVD $AMRN "Protective effects of Eicosapentaenoic acid in adipocyte-br… https://t.co/m4wtrZ5d3c
October 21st 2019, 7:10am
tradejas @tradejas
POSITIVE SCRIPTS for Week Ending 10/11/2019...from IHub by rafunrafun | $AMRN Message Board Posts https://t.co/BNMGjqr8BL
October 21st 2019, 7:10am
IRAMarketReport @IRAMarketReport
Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/MjGItCousF #markets
October 21st 2019, 6:10am
chaffeybreeze @chaffeybreeze
Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/s1XENL9CDP #stocks
October 21st 2019, 6:10am
ConsumerFeed @ConsumerFeed
Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/pADlEnpCA8
October 21st 2019, 6:10am
AmericanBanking @AmericanBanking
Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/Dpe7JvrvWa #stocks
October 21st 2019, 5:10am
WeekHerald @WeekHerald
Amarin $AMRN Rating Increased to Buy at Zacks Investment Research https://t.co/F359p1HOlY
October 21st 2019, 4:10am
registrarjourn @registrarjourn
Zacks Investment Research Lowers Amarin $AMRN to Hold https://t.co/Tz1MUAxrcW
October 21st 2019, 4:10am
EnterpriseLeade @EnterpriseLeade
Zacks Investment Research Lowers Amarin $AMRN to Hold https://t.co/Peh6UwZaqX
October 21st 2019, 4:10am
dispatchtribune @dispatchtribune
Zacks Investment Research Lowers Amarin $AMRN to Hold https://t.co/kEl7EOYua3
October 21st 2019, 4:10am
OlympiaReport @OlympiaReport
Amarin $AMRN Rating Increased to Buy at Zacks Investment Research https://t.co/rpH6187SLU
October 21st 2019, 4:10am
tabuhasna @tabuhasna
RT @MatthewLepoire: $ACST $AMRN https://t.co/Xlh3925Idv
October 21st 2019, 3:10am
dailypoliticaln @dailypoliticaln
Amarin $AMRN Stock Rating Upgraded by BidaskClub https://t.co/TpN2w6h2ue
October 21st 2019, 3:10am
ZolmaxNews @ZolmaxNews
Amarin $AMRN Stock Rating Upgraded by BidaskClub https://t.co/E7XXX42fct
October 21st 2019, 3:10am
WeekHerald @WeekHerald
Amarin $AMRN Given a $35.00 Price Target by Cantor Fitzgerald Analysts https://t.co/sjOtnK0W95
October 21st 2019, 1:10am
OlympiaReport @OlympiaReport
Amarin $AMRN Given a $35.00 Price Target by Cantor Fitzgerald Analysts https://t.co/Xcs1fFSI9U
October 21st 2019, 1:10am
MatthewLepoire @MatthewLepoire
$ACST $AMRN https://t.co/Xlh3925Idv
October 21st 2019, 1:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.